top of page
Argentix logo

Antimicrobial Solutions for Foot and Ankle Surgery

Standard implants. Same procedures. Better Outcomes.

Our Mission

We address the critical need for infection protection within the foot and ankle market with our proprietary polymer platform technology

Our Solutions

Introducing the first cost-effective, high-performance antimicrobial solution engineered to optimize clinical outcomes for high-infection-risk lower extremity procedures

Radiologist reviewing foot images

1

Optimized Foot and Ankle Procedures

Built on proven implant designs and surgical techniques, each implant is enhanced with a durable antimicrobial coating designed to help reduce the risk of infection—without changing the procedure. The result is seamless adoption, consistent performance, and added confidence. Same implants. Same procedures. Now with built-in antimicrobial protection where it matters most.

Hammertoe Surgery

2

Better Patient and Practice Outcomes

By helping to reduce the risk of infection, our proprietary technology supports better outcomes and fewer postoperative complications so patients are less likely to require return visits—benefiting both patient care and practice economics.

Doctor reviewing x-ray with patient

3

Next-Generation Antimicrobial Technology

Designed for higher-infection-risk lower extremity procedures, this proprietary polymer platform employs directly bound, non-leaching silver to deliver broad-spectrum antimicrobial protection at the implant surface. The result is consistent antibacterial activity with no cytotoxic effects of sensitivity—adding protection without changing implant performance. 

Argentix proprietary antimicrobial technology

Our Technology

Over the past decade at Argentix, we have developed a novel antimicrobial biomaterial that irreversibly binds active silver to medical-grade polymers, delivering durable protection without leaching. Effective against gram-positive and gram-negative bacteria, and even multidrug-resistant pathogens, our antimicrobial biomaterial is applied to stainless steel and titanium orthopedic implants via our proprietary surface treatment. The result is a proven reduction in infection risk without compromising safety or altering standard surgical technique.

Argentix Lab

Our Team

Eldon Tate, PhD

CEO & Founder

Eldon developed our state-of-the-art technology while completing his PhD research at Victoria University of Wellington, New Zealand.

eldon.webp

Emma Wrigglesworth, PhD

Technical Lead

Emma is a scientist conducting new R&D at our research facilities in Wellington, New Zealand. Emma brings her expertise in metal-polymer nanocomposite design and characterisation to our R&D team.

e.webp

Stephen Fitzer

Operations Manager

Stephen is our operations manager with experience in both project and production environments. He graduated with an MSc in Engineering Project Management and previously worked on collaborative, complex, and innovative research projects.

steve-f-q4xpy3ws7zrs1gmja9blj6pfddw5b6hq8qgi9zceo4.jpg

News & Events

LSI USA '26

March 16-20, 2026

Waldorf Astoria, Monarch Beach Resort

bottom of page